Lianbang Zhou
Overview
Explore the profile of Lianbang Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuan H, Zhou L, Hu W, Yang M
Sci Rep
. 2025 Jan;
15(1):2997.
PMID: 39848992
Although tamoxifen is commonly utilized as adjuvant therapy for Estrogen Receptor alpha (ERα)-positive breast cancer patients, approximately 30-50% of individuals treated with tamoxifen experience relapse. Therefore, it is essential to...
2.
Li Q, Xu S, Ou Y, Zhou L, Huang F, Jiang W, et al.
J Clin Anesth
. 2024 Jun;
97:111524.
PMID: 38941870
Study Objective: HR18034, composed of the ropivacaine encapsulated in multi-lamellar, concentric circular structure liposomes as the major component and a small amount of free ropivacaine, has performed well in animal...
3.
Gu H, Li W, Zhou L
World J Surg Oncol
. 2024 Mar;
22(1):73.
PMID: 38439060
Objective: To investigate the clinical efficacy and prognostic implication of hand-sewn anastomosis in laparoscopic total gastrectomy (LTG). Methods: Retrospective analysis is adopted to the clinicopathologic data of 112 patients with...
4.
Yu F, Li L, Gu Y, Wang S, Zhou L, Cheng X, et al.
Mol Med
. 2024 Jan;
30(1):9.
PMID: 38216914
Background: Lysine demethylase 5C (KDM5C) has been implicated in the development of several human cancers. This study aims to investigate the role of KDM5C in the progression of colorectal cancer...
5.
Liu Z, Gu Y, Yu F, Zhou L, Cheng X, Jiang H, et al.
Evid Based Complement Alternat Med
. 2022 Oct;
2022:4162354.
PMID: 36193123
Purpose: To assess the association between intestinal venous blood (IVB) circulating tumor cells (CTCs) and clinicopathological parameters in stage I-III colorectal cancer (CRC) patients. Methods: Participants were retrospectively retrieved, who...
6.
Mucin 16 Promotes Colorectal Cancer Development and Progression Through Activation of Janus Kinase 2
Liu Z, Gu Y, Li X, Zhou L, Cheng X, Jiang H, et al.
Dig Dis Sci
. 2021 May;
67(6):2195-2208.
PMID: 33982216
Background: Mucin 16 (MUC16), a cell surface-associated mucin, has been implicated to be upregulated in a large repertoire of malignances. However, its function in the pathogenesis of colorectal cancer (CRC)...
7.
Liu Z, Gu Y, Cheng X, Jiang H, Huang Y, Zhang Y, et al.
Cancer Biomark
. 2020 Dec;
30(3):309-319.
PMID: 33337350
Colorectal cancer is a major public health problem and fourth guiding cause of cancer-induced mortality worldwide. The five-year survival rate for patients with colorectal cancer remains poor, and almost half...
8.
Cheng X, Li X, Gu Y, Zhou L, Tang J, Dai X, et al.
Med Sci Monit
. 2020 Nov;
26:e925772.
PMID: 33219199
BACKGROUND Increasing evidence suggests that the alternative splicing (AS) signature plays a role in the carcinogenesis and prognosis of various cancers. However, the prognostic role of AS in gastric cancer...
9.
Yu G, Jia B, Cheng Y, Zhou L, Qian B, Liu Z, et al.
Am J Transl Res
. 2017 Dec;
9(11):5048-5055.
PMID: 29218103
One of the features for pancreatic cancer is that it is often resistant to chemotherapy treatment, which is one of the major hindrances in the treatment of this malignancy. Previous...